Bookmark

Add to MyYahoo RSS

Viread, Tenofovir News

News on Viread, Tenofovir (generic) continually updated from thousands of sources around the net.

Yesterday | Customer Interaction Solutions

Gilead Announces New Agreement with Medicines Patent Pool for Access...

Gilead Sciences, Inc. announced today at the 20th International AIDS Conference in Melbourne, Australia, a new agreement with the Medicines Patent Pool to expand access to Gilead's investigational drug tenofovir alafenamide for HIV and hepatitis B, contingent on the medicine's U.S. regulatory approval.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, HIV/AIDS, Health, Startups, CGI Pharmaceuticals, Australia, World News,

Tue Jul 15, 2014

POZ

Many People With HIV Could Switch to Newer, Safer Regimens

A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles, according to an analysis of Australians living with the virus, aidsmap reports.

Comment?

Related Topix: Norvir, Ritonavir (generic), Medicine, Ziagen, Abacavir (generic), Sustiva, Efavirenz (generic), Lamivudine (generic), Epivir, Epivir-HBV

Fri Jul 11, 2014

Aidsmap

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

The majority of patients taking antiretroviral therapy that includes drugs associated with long-term side-effects may have the option of switching to a novel regimen that uses newer and safer anti-HIV drugs, according to Australian research published in PLOS One.

Comment?

Related Topix: Norvir, Ritonavir (generic), Medicine, Australia, World News, Ziagen, Abacavir (generic), Sustiva, Efavirenz (generic)

Tue Jul 08, 2014

Pharma Marketing Blog

Has Gilead's Director of Regulatory Affairs Been Hiding Under a...

At the end of June, the FDA sent a Notice of Violation letter to Naumann Chaudry, Director, Regulatory Affairs Advertising and Promotion at Gilead Sciences, citing a sponsored link on Google for VIREAD .

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, AdMob, Hepatitis, Health

Sun Jul 06, 2014

Aidsmap

Stribild

Stribild is a fixed-dose tablet combining 150mg elvitegravir, 200mg emtricitabine, and 245mg tenofovir disoproxil, along with 150mg cobicistat, a boosting agent.

Comment?

Related Topix: Medicine, HIV/AIDS, Health

•••
•••
•••
•••
•••
•••
•••